Metabolic changes in psoriatic skin under topical corticosteroid treatment

BMC Dermatology

Volumn 13, Issue , 2013, Pages

  Sitter, Beathe ^a   Johnsson, Margareta Karin ^a,b   Halgunset, Jostein ^a,b   Bathen, Tone Frost ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Corticosteroids; Metabolites; MR spectroscopy; Psoriasis treatment; Tissue

Indexed keywords

CHOLINE; CLOBETASOL PROPIONATE; CORTICOSTEROID; GLUCOSE; GLYCINE; INOSITOL; TAURINE; BIOLOGICAL MARKER; PHOSPHORYLCHOLINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DERMIS; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METABOLITE; PATHOGENESIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSORIASIS; SKIN BIOPSY; STAINING; SUBCUTANEOUS TISSUE; TISSUE LEVEL; BIOPSY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY; CHOLINE; FEMALE; GLUCOSE; GLYCINE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; PSORIASIS; SKIN;

EID: 84882649518     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-13-8     Document Type: Article

References (19)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009, 361:496-509. 10.1056/NEJMra0804595, 19641206.
2. Gottlieb AB, Dann F. Comorbidities in patients with psoriasis. Am J Med 2009, 122:1150-1159.
3. Hughes J, Rustin M. Corticosteroids. Clin Dermatol 1997, 15:715-721. 10.1016/S0738-081X(97)00020-5, 9313970.
4. Reich K, Bewley A. What is new in topical therapy for psoriasis?. J Eur Acad Dermatol Venereol 2011, 25(Suppl 4):15-20.
5. Millikan LE. Drug therapy in dermatology 2000, New York: Dekker.
6. Bowes J, Barton A. The genetics of psoriatic arthritis: lessons from genome-wide association studies. Discov Med 2010, 10:177-183.
7. Caruso R, Botti E, Sarra M, Esposito M, Stolfi C, Diluvio L, Giustizieri ML, Pacciani V, Mazzotta A, Campione E, Macdonald TT, Chimenti S, Pallone F, Costanzo A, Monteleone G. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med 2009, 15:1013-1015. 10.1038/nm.1995, 19684581.
8. Liu Y, Krueger JG, Bowcock AM. Psoriasis: genetic associations and immune system changes. Genes Immun 2007, 8:1-12. 10.1038/sj.gene.6364351, 17093502.
9. Lindon JC, Beckonert OP, Holmes E, Nicholson JK. High-resolution magic angle spinning NMR spectroscopy: application to biomedical studies. Prog Nucl Magn Reson Spectrosc 2009, 55:79-100.
10. Bathen TF, Sitter B, Sjobakk TE, Tessem MB, Gribbestad IS. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. Cancer Res 2010, 70:6692-6696. 10.1158/0008-5472.CAN-10-0437, 20699363.
11. Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed 2006, 19:30-40. 10.1002/nbm.992, 16229059.
12. Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR in Biomedicine 2002, 15:327-337. 10.1002/nbm.775, 12203224.
13. Martinez-Bisbal MC, Marti-Bonmati L, Piquer J, Revert A, Ferrer P, Llacer JL, Piotto M, Assemat O, Celda B. 1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas. NMR Biomed 2004, 17:191-205. 10.1002/nbm.888, 15229932.
14. Kim YH, Orenberg EK, Faull KF, Wade-Jardetzky NG, Jardetzky O. 1H NMR spectroscopy: an approach to evaluation of diseased skin in vivo. J Invest Dermatol 1989, 92(2):210-216. 10.1111/1523-1747.ep12276738, 2537364.
15. Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol 1966, 30:23-38. 10.1083/jcb.30.1.23, 2106982, 5338131.
16. van Waarde A, Elsinga PH. Proliferation markers for the differential diagnosis of tumor and inflammation. Curr Pharm Des 2008, 14:3326-3339. 10.2174/138161208786549399, 19075707.
17. Borgan E, Sitter B, Lingjaerde OC, Johnsen H, Lundgren S, Bathen TF, Sorlie T, Borresen-Dale AL, Gribbestad IS. Merging transcriptomics and metabolomics-advances in breast cancer profiling. BMC Cancer 2010, 10:628. 10.1186/1471-2407-10-628, 2996395, 21080935.
18. Sitter B, Bathen TF, Singstad TE, Fjosne HE, Lundgren S, Halgunset J, Gribbestad IS. Quantification of metabolites in breast cancer patients with different clinical prognosis using HR MAS MR spectroscopy. NMR Biomed 2010, 23:424-431.
19. Cuperlovic-Culf M, Chute IC, Culf AS, Touaibia M, Ghosh A, Griffiths S, Tulpan D, Leger S, Belkaid A, Surette ME, Ouellette RJ. (1)H NMR metabolomics combined with gene expression analysis for the determination of major metabolic differences between subtypes of breast cell lines. Chem Sci 2011, 2:2263-2270.